Loading…
Lobbying Income
$122K
Filings
19
Unique Clients
2
Active Period
2022–2025
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
SAFE Bet Act of 2025
2025 · third_quarter · Client: PPE CASINO RESORTS MARYLAND, LLC
HR2087/S1033 - SAFE Bet Act
Client expense: — · Firm income: $8,000
Matched citations: HR2087
HR2087/S1033 - SAFE Bet Act
Client expense: — · Firm income: $8,000
Matched citations: S1033
SAFE Bet Act of 2025
2025 · second_quarter · Client: PPE CASINO RESORTS MARYLAND, LLC
HR2087/S1033 - SAFE Bet Act
Client expense: — · Firm income: $12,000
Matched citations: HR2087
HR2087/S1033 - SAFE Bet Act
Client expense: — · Firm income: $12,000
Matched citations: S1033
VALID Act of 2023
2025 · first_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
Matters pertaining to the VALID Act of 2023 (H.R.2369)
Client expense: — · Firm income: —
Matched citations: H.R.2369
VALID Act of 2023
2025 · first_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
Matters pertaining to the VALID Act of 2023 (H.R.2369)
Client expense: — · Firm income: —
Matched citations: H.R.2369
VALID Act of 2023
2024 · fourth_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
Matters pertaining to the VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; Docket No. FDA-2023-N-2177 (FDA's release of the Final Rule on LDTs
Client expense: — · Firm income: —
Matched citations: H.R.2369
VALID Act of 2023
2024 · fourth_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
Matters pertaining to the VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; Docket No. FDA-2023-N-2177 (FDA's release of the Final Rule on LDTs
Client expense: — · Firm income: —
Matched citations: H.R.2369
VALID Act of 2023
2024 · third_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
Matters pertaining to the VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; Docket No. FDA-2023-N-2177 (FDA's release of the Final Rule on LDTs
Client expense: — · Firm income: —
Matched citations: H.R.2369
VALID Act of 2023
2024 · second_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
Matters pertaining to the VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; Docket No. FDA-2023-N-2177 (FDA's release of the Final Rule on LDTs
Client expense: — · Firm income: —
Matched citations: H.R.2369
VALID Act of 2023
2024 · first_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
Matters pertaining to the VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses
Client expense: — · Firm income: —
Matched citations: H.R.2369
VALID Act of 2023
2023 · fourth_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses
Client expense: — · Firm income: $9,000
Matched citations: H.R.2369
VALID Act of 2023
2023 · third_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses
Client expense: — · Firm income: —
Matched citations: H.R.2369
VALID Act of 2023
2023 · second_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses
Client expense: — · Firm income: —
Matched citations: H.R.2369
VALID Act of 2021
2023 · first_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; re-introduced in Spring of 2023 as H.R.2639
Client expense: — · Firm income: —
Matched citations: H.R.4128
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2023
2023 · first_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; re-introduced in Spring of 2023 as H.R.2639
Client expense: — · Firm income: —
Matched citations: H.R.2639
VALID Act of 2021
2023 · first_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; re-introduced in Spring of 2023 as H.R.2639
Client expense: — · Firm income: —
Matched citations: S.2209
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses FDASLA (S.4348); Provisions that negatively impact CLIA-approved laboratory businesses pertaining to the FDA's authority to collect certain fees and regulate certain products House User Fees (H.7667) Omni (H.R.2617)
Client expense: — · Firm income: $22,500
Matched citations: H.R.2617
VALID Act of 2021
2022 · fourth_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses FDASLA (S.4348); Provisions that negatively impact CLIA-approved laboratory businesses pertaining to the FDA's authority to collect certain fees and regulate certain products House User Fees (H.7667) Omni (H.R.2617)
Client expense: — · Firm income: $22,500
Matched citations: H.R.4128
VALID Act of 2021
2022 · fourth_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses FDASLA (S.4348); Provisions that negatively impact CLIA-approved laboratory businesses pertaining to the FDA's authority to collect certain fees and regulate certain products House User Fees (H.7667) Omni (H.R.2617)
Client expense: — · Firm income: $22,500
Matched citations: S.2209
FDASLA Act of 2022
2022 · fourth_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses FDASLA (S.4348); Provisions that negatively impact CLIA-approved laboratory businesses pertaining to the FDA's authority to collect certain fees and regulate certain products House User Fees (H.7667) Omni (H.R.2617)
Client expense: — · Firm income: $22,500
Matched citations: S.4348
VALID Act of 2021
2022 · third_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses FDASLA (S.4348); Provisions that negatively impact CLIA-approved laboratory businesses pertaining to the FDA's authority to collect certain fees and regulate certain products
Client expense: — · Firm income: $35,000
Matched citations: H.R.4128
VALID Act of 2021
2022 · third_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses FDASLA (S.4348); Provisions that negatively impact CLIA-approved laboratory businesses pertaining to the FDA's authority to collect certain fees and regulate certain products
Client expense: — · Firm income: $35,000
Matched citations: S.2209
FDASLA Act of 2022
2022 · third_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses FDASLA (S.4348); Provisions that negatively impact CLIA-approved laboratory businesses pertaining to the FDA's authority to collect certain fees and regulate certain products
Client expense: — · Firm income: $35,000
Matched citations: S.4348
VALID Act of 2021
2022 · second_quarter · Client: COALITION FOR INNOVATIVE LABORATORY TESTING, INC.
VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses
Client expense: — · Firm income: $35,500
Matched citations: H.R.4128
Source: Senate LDA